CorPath® GRX Neuro Study
CorPath® GRX Neuro Study
The primary objective of this study is to evaluate the effectiveness and safety of
 robotic-assisted endovascular embolization procedures compared to objective performance
 criteria for traditional, manual operation based on the scientific literature.
This is a prospective, single-arm, international, multi- center, non-inferiority study to
 evaluate the effectiveness and safety of the CorPath GRX System for endovascular cerebral
 aneurysm embolization compared to historical controls. Subject selection requires a clinical
 indication for endovascular coil and/or stent-assist coiling embolization of cerebral
 aneurysms.
Inclusion Criteria:

 1. Age ≥ 18 years

 2. At least one cerebral aneurysm (unruptured or ruptured) with indication for
 endovascular treatment; dome to neck ratio>1.5;

 3. The Investigator deems the procedure appropriate for robotic-assisted endovascular
 treatment;

 4. The subject has been informed of the nature of the study, agrees to its provisions and
 has provided written informed consent.

 Exclusion Criteria:

 1. Failure/inability/unwillingness to provide informed consent.

 2. The Investigator determines that the subject or the neurovascular anatomy is not
 suitable for robotic-assisted endovascular treatment.